chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Malaise, Myalgia
Clinical narrative: Tiredness; feeling unwell; joint pain; chills; muscle pain; This is a spontaneous report from a contactable non-health care professional (patient). An 83 Year(s) old male patient received BNT162B2 (Pfizer-BioNTech COVID Vaccine), batch/lot number# EL9269, via unspecified route of administration on his left arm as first dose, single on 07Feb2021 at 12:45, (age at vaccination 83 years) for Covid-19 immunization. Patient's medical history was not reported. The patient was allergic to Thimerosal, lactose and cucumber. Concomitant medication included lisinopril 10 milligram (mg) for chest congestion relief PE. Patient did not receive any other vaccine within four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Mar2021 at 09:00, the patient experienced chills, feeling unwell, joint pain, muscle pain and tiredness. He did not receive treatment for the events. The patient was recovering from all the events. No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Paraesthesia, Sensory loss
Clinical narrative: sensory deficit; left arm aching; left arm paresthesia; This is a spontaneous report from a non - contactable other healthcare professional. A 61-years-old female patient received a single dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE ) ( Lot number = EN6205 ) via an unspecified route of administration on 16Mar2021 ( at the age of 61-years-old ) as a first dose for COVID-19 vaccination. Medical history and concomitant medications were not reported.  On 16Mar2021, during waiting period of 15 minutes after the vaccination, the patient experienced left arm paresthesia and aching. She had denied for rash, hives and SOA. But sensory deficit was present. Patient was discharged as she was stable to go home. The outcome of these reactions are unknown. No follow-up attempts are needed and no further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: During her 15 minute waiting period after the injection, the patient began to experience lightheadedness.  She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat; This is a spontaneous report received from a contactable other health care professional. A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EN6205) via an unspecified route of administration on 16Mar2021 as single first dose for COVID-19 vaccination. Medical history, concomitant medication and past drug were not reported and no known allergies. On 16March2021 the patient experienced light-headedness after 15 minutes vaccination during the waiting period, the patient denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, dizziness, facial swelling, lip swelling and tongue swelling. The patient did not undergo lab tests and procedures. It was unknown the patient received any other vaccine within 4 weeks prior to the covid-19. Prior to vaccination, the patient was not diagnosed with COVID-19 and had not been tested for COVID-19, Since having the vaccination. Therapeutic measures were taken as a result of Event and included treatment with water, snacks and Tylenol on an unknown date. The outcome of the event light-headedness was recovering. It was reported that the patient was stable to go home and follow up with primary care providers (pcp). No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Headache, Pain, Vaccination site pain
Clinical narrative: body aches; headache; coughing; chills; soreness at site on left arm; This is a spontaneous report received from a contactable consumer, the patient. A 65-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch number: EN6208), dose one via unspecified route of administration on the left arm on 10Mar2021 at 15:45 (at the age of 65 years old) as a single dose for COVID-19 immunisation. Medical history included nasal congestion, bee sting allergy, high cholesterol. Concomitant medications included Atorvastatin 20 MG, vitamin and nasal spray within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Mar2021 within several hours of receiving vaccination there was some soreness at site on left arm. On 14Mar2021 the patient also experienced body aches, headache, coughing and chills (within 3-4 days after shot). The patient did not receive any treatment for the events. The clinical outcome for body aches, headache, coughing and chills was recovering and for soreness at site on left arm was not reported. No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: weakness generalized; .                  This is a spontaneous report from a non contactable other health care professional, the patient. A 40 year old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration, and anatomical site as 2nd dose, single, on 16MAR2021 (at the age of 40-years-old) for COVID-19 immunization. Patient past drug history include BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: not known) via an unspecified route of administration, anatomical site as 1st dose, single, on unspecified date for COVID-19 immunization. On 16MAR2021 after vaccination, during her 15 minute waiting period after the injection, the patient began to experience generalized weakness, need for a quick snack. She denied rash, shortness of breath, difficulty swallowing or syncope treatment included: snacks. It was reported that follow up response to treatment was good. Patient discharge: stable to go home. Clinical outcome of the event generalized weakness was reported as recovered .No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Continued Left shoulder pain.; This is a spontaneous report from a contactable Health care professional, patient qualified nurse. A 45-years-old female patient received BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE) (Lot No: unknown) via an unspecified route of administration, administered on the left arm on Jan2021at 08.00 am (at the age of 45-years old) as a single first dose for COVID-19 Immunization. The second dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE) (Lot No: unknown) via an unspecified route of administration, administered on the left arm on Jan2021at 08.00 am (at the age of 45-years old) as a single first dose for COVID-19 Immunization. Medical history and concomitant medications were not reported and did not have any allergies to food medication or other product. The patient was not pregnant at the vaccination. The patient did not receive any other vaccine within 4 weeks prior to the covid-19 vaccination and other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19, Since the vaccination, the patient had not been tested for COVID-19. The patient experienced Left shoulder pain on 29Jan2021 at 9.00pm which continued. Therapeutic measures were taken for the adverse event which included Steroid shot on an unknown date. The clinical outcome of the event Left shoulder pain was reported as not recovered. Information about lot/batch number cannot be obtained. No further information is expected
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: SWELLIN OF THE HANDS AND FEET AND LEGS; SWELLIN OF THE HANDS AND FEET AND LEGS; SWELLIN OF THE HANDS AND FEET AND LEGS; This is a spontaneous report from a contactable, consumer. A 82-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EN6206) 1st dose on 11Mar2021 at 09:45am, solution for injection in the right arm, via unspecified route of administration for Covid 19 immunisation. Medical history included diabetes. The patient had a history of codeine allergy . The Patient has tested as negative and the test name was not provided on unspecified. Since the vaccination, the patient had been tested for COVID-19. On 12Mar2021, the patient had swelling of the hands and feet and legs. The patient has recovering from the event of swelling of the hands and feet and legs at the time of reporting. No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash vesicular
Clinical narrative: right is the worst rash with blisters; I have a rash on both arms; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE); Lot/batch no: En6200) via unspecified route in the left arm as a single dose on 03Mar2021 at 02:00 for COVID-19 immunization. The patient's past drug history included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/Batch Number: el3302) via an unspecified route of administration in the left arm, as a single dose on 04Feb2021 at 02:00 for COVID-19 immunization. The most recent COVID-19 vaccine was administered in the public health clinic administration facility. The patient was allergic to sulphur. The patient's relevant medical history included asthma. Concomitant medications were not provided. The patient had received other vaccines (unspecified) within 4 weeks prior to the COVID-19 vaccine. It was unknown, if the patient was diagnosed with COVID-19 prior to the vaccination. It was unknown, if the patient had been tested for COVID-19 since the vaccination. On 10Mar2021, the patient had a rash on both arms and the right was the worst rash with blisters. The patient received Benadryl and cortizone 10 cream as treatment for the adverse events. The clinical outcome of the events was reported as not recovered/not resolved/ongoing.   No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Increased tinnitus/ringing in ears; This is a spontaneous report from a contactable consumer. A male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/Batch Number: UNKNOWN, Dose: UNKNOWN), via an unspecified route of administration on left arm on 23Feb2021 at 1.00 pm as Covid-19 immunization. No medical history and concomitant medications were reported by the patient. The patient is allergic to sulfa drugs. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received omeprazole (UNKNOWN MANUFACTURER), Allopurinol (UNKNOWN MANUFACTURER), Tadalafil (UNKNOWN MANUFACTURER), Vitamins (UNKNOWN MANUFACTURER) within 2 weeks of vaccination. Prior to the vaccination the patient was not diagnosed with Covid-19. Since vaccination patient was not tested for covid-19. The patient past medication history was not reported. The patient experienced an increase in tinnitus on 01Mar2021.the patient also reported that he had some tinnitus before but it was more noticeable and bothersome. The patient did not receive any treatments for the events. The clinical outcome of the event was unknown. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to extreme temperature, Raynaud's phenomenon, Skin discolouration
Clinical narrative: Raynauld's phenomenon-like symptoms with hands, fingers.; Skin temperature cold with or without exposure; skin colouration (bluish ,white); This is a spontaneous report from a contactable Nurse. A 39-year-old female patient receive BNT162B2 (PFIZER- BIONTECH COVID-19mRNA VACCINE; Lot/Batch Number: EL3248), via an unspecified route of administration on 06Jan2021(at the age of 39-years-old) as a single dose for COVID-19 immunization. Medical history include rheumatoid arthritis and patient was allergic to Azhitromycin . The patient concomitant medications include Vitamin, Iron, Bcomplex, Adderal and Turmeric. Reported patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. On 01Feb2021 patient experienced ,Raynaulds phenomenon ,skin discolouration, and skin temperature change cold with or without exposure .Therapeutic measures taken as amlodipine medication for the reported event. The clinical outcomes of reported events were not recovered/ not resolved.  No follow up attempts are needed. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vertigo
Clinical narrative: Vertigo lasted about 3 hours; Enlarged Nodes underneath Armpit where I received injection shot lasted for 35 days.; This is a spontaneous report from a contactable consumer, the patient.   A 69-year-old non pregnant female patient received BNT162B2 (Pfizer BioNTech Covid 19 Vaccine) (Lot/batch no: EL9264) via unspecified route of administration at right arm as a single dose for COVID-19 immunisation on 12Jan2021 at 10:00 am. No medical history and concomitant drugs were reported. The patient was allergic to medications, food, or other products. Reported patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The patient experienced vertigo lasted about 3 hours and enlarged nodes underneath armpit where she received injection shot lasted for 35 days on 12Jan2021 at 10:15 am. No therapeutic measures were taken as a result of these events. The patient did not receive any treatment for the events. The clinical outcome of the event vertigo and enlarged nodes underneath armpit was recovering. No follow-up attempts are needed. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: Swelling in both hands; This is a spontaneous report from a contactable consumer, a patient. A 69-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) on 10Mar2021 at 02:00 pm (at the age of 69-year-old) on right arm as a single dose for COVID-19 vaccination. Medical history includes heart condition from an unknown date. The patient had no known allergies. Concomitant drugs include Apixaban (ELIQUIS), Motropolo(MANUFACTURER UNKNOWN), Amiodarone(MANUFACTURER UNKNOWN) and Stain(MANUFACTURER UNKNOWN). Patient was not diagnosed with COVID-19 prior to the vaccination. Patient has not tested for COVID-19 since having the vaccine and did not receive any vaccine 4 weeks prior to COVID-19 vaccination. The patient experienced swelling in both hands on 15Mar2021.Therapeutic measures for swelling of both hands includes Script for steroid pack and Benadryl on an unknown date. The clinical outcome of swelling in both hands was recovered/resolved. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Eye swelling, Headache, Hypoaesthesia, Magnetic resonance imaging
Clinical narrative: numbness and tingling on right side of face and in right arm and shoulder.; numbness and tingling on right side of face and in right arm and shoulder.; tingling on right side of face and in right arm and shoulder.; swollen right eye; nausea; severe headache; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH6198; DOSE NUMBER: 1) via an unspecified route of administration on her left arm on 06Mar2021, as single dose for Covid-19 vaccination (at the age of 46 years). Medical history and concomitant medications were not reported. No other vaccines were administered within four weeks. The patient has allergy to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 20:00 (reported as 6 days post-vaccination), the patient developed nausea, swollen right eye and severe headache that had persisted for several days then. On 15Mar2021 (reported as day 3), the patient developed numbness and tingling on right side of face and in right arm and shoulder. The patient underwent Computed Tomogram (CT) scan and Magnetic Resonance Imaging (MRI) (dates and results not reported). The patient received treatment for the events (treatment details not reported). She was taken to emergency room due to the events. The outcome of all the events was unknown. No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Paraesthesia
Clinical narrative: numbness and tingling on right side of face and in right arm and shoulder.; numbness and tingling on right side of face and in right arm and shoulder.; tingling on right side of face and in right arm and shoulder.; swollen right eye; nausea; severe headache; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EH6198; DOSE NUMBER: 1) via an unspecified route of administration on her left arm on 06Mar2021, as single dose for Covid-19 vaccination (at the age of 46 years). Medical history and concomitant medications were not reported. No other vaccines were administered within four weeks. The patient has allergy to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Mar2021 at 20:00 (reported as 6 days post-vaccination), the patient developed nausea, swollen right eye and severe headache that had persisted for several days then. On 15Mar2021 (reported as day 3), the patient developed numbness and tingling on right side of face and in right arm and shoulder. The patient underwent Computed Tomogram (CT) scan and Magnetic Resonance Imaging (MRI) (dates and results not reported). The patient received treatment for the events (treatment details not reported). She was taken to emergency room due to the events. The outcome of all the events was unknown. No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Ear swelling, Erythema, Pruritus, Rash, Rash erythematous
Clinical narrative: scattered rashes; Rashes, redness on her face and neck; Itching all over the body; swelling of eyelids; Itching of ear; Redness of ear; Swelling of right ear; This is a spontaneous report from a contactable health care professional, the patient. A 31-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0142; DOSE NUMBER: 1) via unspecified route of administration on the left arm on 31Dec2020 at 08:00 (at the age of 31-year-old at vaccination) as a single dose for COVID-19 vaccination. On 21Jan2021 at 11:00, the patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262; DOSE NUMBER: 2) via unspecified route of administration in the left arm. Medical history of the patient included cholecystectomy in 2014. The patient was allergic to Norgestimate and Ethinyl estradiol (TRINESSA). Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received concomitant medications within 2 weeks prior to the COVID vaccine, but details were not provided. On 04Feb2021, the patient started having redness, itching and swelling on her right ear and continued on 05Feb2021. On 06Feb2021, it extended towards her upper cheeks. On 07Feb2021, event spread to left ear. On an unknown date, the patient also had swelling of eyelids, itching all over her body and scattered rashes. The patient took Cetirizine hydrochloride (ZYRTEC) for two days with no relief and switched to Diphenhydramine hydrochloride (BENADRYL) for two days and still had no relief. The patient went to the emergency department for fear of her throat closing, scheduled for a dermatologist who prescribed her a steroid cream (unspecified) for 2 weeks, which worked. But after 2 weeks, she had to stop the cream. Since then, she had nonstop itching all over her body. Patient also had intermittent swelling of eyes and, rashes, redness on her face and neck till the date of report. Any other antihistamine did not work for her. The clinical outcome of the events redness, itching and swelling on right ear, swelling of eyelids, itching all over her body, scattered rashes and, rashes, redness on face and neck was not resolved. No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling of eyelid
Clinical narrative: scattered rashes; Rashes, redness on her face and neck; Itching all over the body; swelling of eyelids; Itching of ear; Redness of ear; Swelling of right ear; This is a spontaneous report from a contactable health care professional, the patient. A 31-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0142; DOSE NUMBER: 1) via unspecified route of administration on the left arm on 31Dec2020 at 08:00 (at the age of 31-year-old at vaccination) as a single dose for COVID-19 vaccination. On 21Jan2021 at 11:00, the patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262; DOSE NUMBER: 2) via unspecified route of administration in the left arm. Medical history of the patient included cholecystectomy in 2014. The patient was allergic to Norgestimate and Ethinyl estradiol (TRINESSA). Prior to vaccination, the patient was not diagnosed with COVID-19. Since vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received concomitant medications within 2 weeks prior to the COVID vaccine, but details were not provided. On 04Feb2021, the patient started having redness, itching and swelling on her right ear and continued on 05Feb2021. On 06Feb2021, it extended towards her upper cheeks. On 07Feb2021, event spread to left ear. On an unknown date, the patient also had swelling of eyelids, itching all over her body and scattered rashes. The patient took Cetirizine hydrochloride (ZYRTEC) for two days with no relief and switched to Diphenhydramine hydrochloride (BENADRYL) for two days and still had no relief. The patient went to the emergency department for fear of her throat closing, scheduled for a dermatologist who prescribed her a steroid cream (unspecified) for 2 weeks, which worked. But after 2 weeks, she had to stop the cream. Since then, she had nonstop itching all over her body. Patient also had intermittent swelling of eyes and, rashes, redness on her face and neck till the date of report. Any other antihistamine did not work for her. The clinical outcome of the events redness, itching and swelling on right ear, swelling of eyelids, itching all over her body, scattered rashes and, rashes, redness on face and neck was not resolved. No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Dizziness; This is a spontaneous report received from a contactable consumer, the patient. A 68-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: EN6201) in the left arm on 23Feb2021 at 13:15 (at the age of 68-years-old) and second dose (Lot/batch no: EN6208) in the left arm on 16Mar2021 at 13:15 as a single dose via unspecified route of administration for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications included Amlodipine/Benazepril (10-20mg) and Carvedilol (6.25, units unspecified) for an unknown indication from an unknown date to unknown date. The patient previously took Amoxicillin and experienced drug allergy on an unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 10Mar2021, the patient experienced dizziness, when getting up, laying down and bending over. The patient did not receive treatment for the event. The clinical outcome of the dizziness was not recovered. No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain
Clinical narrative: Severe Ear ache; This is a spontaneous report from a contactable non-health care professional, the patient. A 60-year-old non-pregnant female patient received BNT162B2 (BNT162B2) Lot/batch no: EP7534, via an unspecified route of administration in the left arm on 15Mar2021 at 11: 00 (at the age of 60-year-old) as first dose, single for COVID-19 immunization. Medical history included complex regional pain syndrome (CRPS). The patient did not have any allergies to medications, food or other products. Concomitant medications included dexamethasone and ropivacaine for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Mar2021 at 19:15, the patient experienced severe earache. The patient was not recovered from the event. No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: Fatigue
Clinical narrative: fatigue; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 09Mar2021 at 09:30AM (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension .The patient also reported allergy to shellfish. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient's concomitant medications included Cozaar (MANUFACRURER UNKNOWN), vitamin B12 (MANUFACRURER UNKNOWN), vitamin D (MANUFACRURER UNKNOWN) all for unknown indication from unknown dates and unknown if its ongoing. On 14Mar2021 (Day 5), the patient started to feel fatigue but on 16Mar2021 (day 7), it was so intense that prevented him to do habitual physical activity. The patient who was an athlete, preparing for a triathlon, was not able to finish a 4-mile run, which was very simple to his fitness level. The patient was treated for the event fatigue with Advil (MANUFACRURER UNKNOWN). The clinical outcome of the event fatigue was not recovered. No follow up attempts are possible. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19, UNK
Symptoms: Drug interaction, Fatigue, Loss of personal independence in daily activities
Clinical narrative: fatigue; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 09Mar2021 at 09:30AM (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension .The patient also reported allergy to shellfish. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient's concomitant medications included Cozaar (MANUFACRURER UNKNOWN), vitamin B12 (MANUFACRURER UNKNOWN), vitamin D (MANUFACRURER UNKNOWN) all for unknown indication from unknown dates and unknown if its ongoing. On 14Mar2021 (Day 5), the patient started to feel fatigue but on 16Mar2021 (day 7), it was so intense that prevented him to do habitual physical activity. The patient who was an athlete, preparing for a triathlon, was not able to finish a 4-mile run, which was very simple to his fitness level. The patient was treated for the event fatigue with Advil (MANUFACRURER UNKNOWN). The clinical outcome of the event fatigue was not recovered. No follow up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Insomnia
Clinical narrative: Fatigue; sleepless night; This is a spontaneous report from a contactable Non health care professional consumer, the patient. A 55-Years-old adult male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA vaccine; Lot number: EN6207 and expiration date not provided) dose no:1 on right arm via an unspecified route on 13Mar2021 at 11:00(at the age of 55-years-old) as a single dose for COVID-19 vaccination (COVID-19 Immunisation). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Medical history included allergic to Morphine, Dilaudid and the past medical history included bipolar 1 disorder. Concomitant medications included Lithium carbonate, valproate, quetiapine and Pramipexole. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. After the vaccination, on 14Mar2021 at 02:00 AM patient experienced fatigue lasted for 2 days and sleepless night on the first night. The patient recovered from the events Fatigue and Insomnia at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Injection site pain, Pain
Clinical narrative: Ache; Right arm sore at injection site; Lump/pain in right arm pit starting two days after shot and continuing for a week after the shot; Tired; This is a spontaneous report from a contactable Consumer. A 57-year-old non-pregnant female patient received BNT162B2(PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot/batch number: EN6206), via an unspecified route of administration in the right arm on 10Mar2021 at 01:15PM (at the age of 57-years-old) as a single dose for COVID-19 Immunisation. The patient was allergic to shellfish, latex, vicodin and percoset. concomitant medications were not included. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to the vaccine and she did not receive any other vaccines within 2 weeks post vaccination. On 10Mar2021 at 08:00 PM the patient experienced Right arm sore at injection site, tired and achy for 3 days after shot, lump/pain in right arm pit starting two days after shot and continuing for a week after the shot (as reported). It was unknown if the patient received the treatment for the events. The clinical outcome of the events we unknown. No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Malaise, Pruritus
Clinical narrative: feeling ill; itching on back; fatigue; rash and itching on arms, torso, neck and face.; headache; Diarrhea; Rash, redness and itching on back; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch Number: EN6203), via an unspecified route of administration on Left Arm on 26Feb2021 at 15:45 hours (at the age of 53-years-old and the patient was not pregnant at the time of vaccination) as a single dose for COVID-19 Immunisation. Medical history included that patient had seasonal allergies and also to Sulfa drugs. Concomitant medications included Zinc (MANUFACTURER: UNKNOWN), Vitamins (MANUFACTURER: UNKNOWN), Aspirin (MANUFACTURER: UNKNOWN), and Allergy Medicine (MANUFACTURER: UNKNOWN). Past drug history has not been provided. Prior to vaccination, the patient was not diagnosed with COVID-19 and did not receive any other vaccine within four weeks. Since the vaccination, patient has not been tested for COVID-19. On first day of vaccination, patient was feeling ill and experienced Diarrhea, Headache, and Fatigue. On Third day of vaccination, patient experienced Rash, Redness and Itching on the back. On the Fifth day, the patient experienced Rash and Itching on arms, torso, neck and face. The adverse events resulted in the Doctor/Health care professional/Clinical visit. Therapeutic measures were taken as a result of the events and it included treatment with Benadryl from unspecified start date to end date. The clinical outcome of the all events were recovered. No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash erythematous
Clinical narrative: feeling ill; itching on back; fatigue; rash and itching on arms, torso, neck and face.; headache; Diarrhea; Rash, redness and itching on back; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch Number: EN6203), via an unspecified route of administration on Left Arm on 26Feb2021 at 15:45 hours (at the age of 53-years-old and the patient was not pregnant at the time of vaccination) as a single dose for COVID-19 Immunisation. Medical history included that patient had seasonal allergies and also to Sulfa drugs. Concomitant medications included Zinc (MANUFACTURER: UNKNOWN), Vitamins (MANUFACTURER: UNKNOWN), Aspirin (MANUFACTURER: UNKNOWN), and Allergy Medicine (MANUFACTURER: UNKNOWN). Past drug history has not been provided. Prior to vaccination, the patient was not diagnosed with COVID-19 and did not receive any other vaccine within four weeks. Since the vaccination, patient has not been tested for COVID-19. On first day of vaccination, patient was feeling ill and experienced Diarrhea, Headache, and Fatigue. On Third day of vaccination, patient experienced Rash, Redness and Itching on the back. On the Fifth day, the patient experienced Rash and Itching on arms, torso, neck and face. The adverse events resulted in the Doctor/Health care professional/Clinical visit. Therapeutic measures were taken as a result of the events and it included treatment with Benadryl from unspecified start date to end date. The clinical outcome of the all events were recovered. No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Ocular discomfort
Clinical narrative: Eye discomfort; This is a spontaneous report from a non - contactable other healthcare professional. A 60-years-old female patient received a single dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE ) ( Lot number = not known ) via an unspecified route of administration in left arm on 11Mar2021 ( at the age of 60-years-old ) at 09:45am as a first dose for COVID-19 vaccination. Medical history included that patient was diabetic. Since the vaccination patient had not been tested for covid-19. The patient had took diabetic medicines as a concomitant medications within two weeks of vaccination. The patient did not received any other vaccine within four weeks prior to the vaccination. On 12Mar2021, after 24 hours post vaccination the patient experienced discomfort in the ocular eye. Patient did not experienced any pain. The outcome of this reaction is not recovered. Information about lot/batch number cannot be obtained and no further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: I got the first vaccine (Covid Vaccine) already administered and then I actually contracted corona virus about a week and a half later/tested positive for Covid-19; This is a spontaneous report from a contactable consumer (patient himself). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 22Feb2021 as 1st dose single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Any unaddressed medical questions were not referred or forwarded to Medical Information. Patient stated that on the 22Feb2021, he got the first vaccine (Covid Vaccine) already administered and then I actually contracted corona virus about a week and a half later on 03Mar2021. He was scheduled to get the second vaccine on 17Mar2021 (Covid Vaccine). He was scheduled for 2nd dose more than 21 days. His question was, does he had to delay his second vaccine or he was allowed to get it as he tested positive. He was little confused and he was not able to get an answer on getting the second vaccine. The outcome of the event was unknown.   Follow-up (14Mar2021): This is a follow-up spontaneous report from a Pfizer-sponsored program COVAX US Support. A contactable consumer (patient) reported that included patient gender, clarified vaccine start date, event onset date as updated in the initial narrative.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Limb discomfort, Pain
Clinical narrative: legs feel heavy; Pain at injection site; Body aches; Chills; Teeth hurt; Headache; Very tired; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown, Dose number: 1) via an unspecified route of administration in the left arm on 15Mar2021, 13:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient medical history includes hereditary sensory neuropathy, Hashimotos thyroiditis. The patient concomitant medications include Levothyroxine, Bit D, Immunity vitamin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021, the patient experienced Headache, very tired, teeth hurt, legs feel heavy, body aches, chills, vaccination site pain. The patient was not treated for the adverse events. The clinical outcome of the events Headache, very tired, teeth hurt, legs feel heavy, body aches, chills, vaccination site pain was resolving at the time of the report. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Toothache, Vaccination site pain
Clinical narrative: legs feel heavy; Pain at injection site; Body aches; Chills; Teeth hurt; Headache; Very tired; This is a spontaneous report received from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: unknown, Dose number: 1) via an unspecified route of administration in the left arm on 15Mar2021, 13:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. The patient medical history includes hereditary sensory neuropathy, Hashimotos thyroiditis. The patient concomitant medications include Levothyroxine, Bit D, Immunity vitamin. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not have any allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021, the patient experienced Headache, very tired, teeth hurt, legs feel heavy, body aches, chills, vaccination site pain. The patient was not treated for the adverse events. The clinical outcome of the events Headache, very tired, teeth hurt, legs feel heavy, body aches, chills, vaccination site pain was resolving at the time of the report. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Hypoaesthesia, Paraesthesia
Clinical narrative: tingling sensation on chest and eventually went up to left side of the neck and left side of the face.; Tightness in chest; Pressure in chest; numbness in chest; This is a spontaneous report from a contactable other healthcare professional. A 32-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208), via an unspecified route of administration in the left arm on 14Mar2021 (at the age of 32-years-old), as a first single dose for COVID-19 vaccination. The patient's medical history included penicillin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. Concomitant medications included Xanax (MANUFACTURER UNKNOWN), Motrin (MANUFACTURER UNKNOWN) and Zofran (MANUFACTURER UNKNOWN) for an unknown indication from an unspecified date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 14Feb2021 at 22:00, the patient experienced tightness, pressure and numbness on chest 9 hours after vaccine. On 15Feb2021, the patient still had numbness and tingling sensation on her chest and eventually went up to her left side of the neck and left side of the face. The patient did not receive any treatment for the adverse events. The clinical outcome of chest tightness, chest pressure and tingling sensation was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swollen tongue
Clinical narrative: Rash on face; Swollen Tongue; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received BNT162B2 (Pfizer BioNTech covid 19 vaccine) (Lot/batch no.: EN6206), first dose via unspecified route of administration on right arm for COVID-19 immunisation on 05Mar2021 at 18:00. Medical history included PSA and rheumatoid arthritis. The patient had not reported any allergies. Concomitant medication included Xjejanz (MANUFACTURER UNKNOWN) within 2 weeks for an unknown indication. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient had not been diagnosed with COVID-19 prior to the vaccination and had not tested positive for COVID-19 after vaccination. On 09Mar2021 patient had experienced rash on face and swollen tongue. Therapeutic measures were not taken for the events. The clinical outcome of the events of rash on face and swollen tongue was unresolved. No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Cold sweat, Diarrhoea
Clinical narrative: Stomach cramps; Diarrhea; Cold sweats; This is a spontaneous report received from a contactable consumer, the patient. A 40-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot/batch no: Ep6955) via an unspecified route of administration in the left arm on 15Mar2021 at 12:00 PM (at the age of 40-years-old) as a single dose for COVID-19 vaccination. The patient medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021, the patient experienced Diarrhea, cold sweats and stomach cramps. The patient was not treated for the adverse events. The clinical outcome of the events Diarrhea, cold sweats, and stomach cramps was resolved on an unknown date at the time of the report. No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives; welts; This is a spontaneous report from a a contactable pharmacist. This report received from a 48 year old male patient received BNT162B2 (Pfizer BioNTech Covid 19 mRNA Vaccine) from batch/lot number EN6208 via an unspecified route of administration on 24Feb2021 17:00 for COVID-19 immunisation on left arm.The other concomitant drug used was omeprazole and drug used to treat adverse drug reaction was hydroxyzine. No patient medical history included. The patient experienced hives and welt on 13Mar2021 and events were not recovered. The action taken was not applicable. The clinical outcome of the events was not recovered. No Allergies to medications food, or other products were reported. Ethnicity information was available. Race information was available. No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Nausea, Palpitations
Clinical narrative: HEART RACING SENSATION; ANXIOUS MOOD; Nausea; This is a spontaneous report from a contactable Healthcare Professional. A 67 years old male patient received BNT162B2 (COMIRNATY; Lot Number: EN6207), via an unspecified route of administration on 15Mar2021 (at an age of 67 years old), as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Its unknown whether Prior to the vaccination, the patient was diagnosed with Covid-19 or not. On 15Mar2021, the patient experienced slight nausea, heart racing and also was in anxious mood during the 15 minutes waiting period after the injection (vaccination). Patient denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness and hoarseness. Patient did not receive any treatment for the adverse events. Patient was stable to go home and agreed for follow up with PCP. The clinical outcome of event slight nausea, anxious mood and heart racing were not reported. No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Peripheral swelling
Clinical narrative: Headache; Hot red swollen arm; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old female patient received second dose of BNT162B2{COVID-19 MRNA VACCINE BIONTECH, batch/lot number: EM9809], via an unspecified route of administration in the left arm on 13Mar2021 01:30 PM {age at vaccination 66 years} as a single dose for COVID-19 immunisation. Medical history includes diabetes and Chronic Obstructive Pulmonary Disease (COPD). The patient received the first dose of BNT162B2 [COVID-19 MRNA VACCINE BIONTECH, batch/lot number: EN6208], via unspecified route of administration in the left arm on 20Feb2021 01:45 PM as a single dose for COVID-19 immunisation The patient had not been diagnosed with COVID-19 before and after vaccination. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient didn't have any allergies related to medication, food, or other products. Concomitant medications were reported however, it was not specified. The patient experienced Headache, Hot red swollen arm and fatigue on 16Mar2021 at 04:45 AM. Adverse event resulted in emergency room / department or urgent care. It was reported that patient not received any treatment for the reported events. The clinical outcome of the events was unknown. No follow-up attempts are needed. No further information is expected.